C1QBP and benign recurrent intrahepatic cholestasis: Upregulation of C1QBP was found to be the most frequent alteration type in metaplastic breast cancer (MBC), breast invasive carcinoma (BRIC), breast invasive ductal carcinoma (BRIDC), and breast invasive lobular carcinoma (BRILC).